-
-
-
-
-
-
-
iBio, Inc. (IBIO) Acquires RubrYc Therapeutics’ AI Drug Discovery Platform and Pipeline
-
-
-
-
-
-
-
iBio to Report Fiscal 2022 First Quarter Financial Results and Provide Corporate Update on Monday, November 15, 2021
-
-
-
-
-
-
-
Pre-Open Movers 12/02: (TG) (IBIO) (AIV) Higher; (OVID) (IRTC) (WKHS) Lower (more...)
-
-
-
-
-
-
-
iBio Estimates ~500 Million Dose Capacity for COVID-19 Vaccine from its FastPharming Facility™
-
-
-
-
-
-
-
iBio, Inc. (IBIO) Announces Development of Proprietary COVID-19 Vaccine Candidates
-
-
-
-
-
-
-
iBio and CC-Pharming Initiate Joint Development of Coronavirus Vaccine
-
-
-
-
-
-
-
iBio Reports Progress on its Bio-Better Rituximab Collaboration with CC-Pharming
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

